Mahmut Büyükşimşek

20PUBLICATIONS
106CO-AUTHORS
Nutrigenomics and personalised nutritionPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 26, 2026
Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study.

|Sep 26, 2026
Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?

|Aug 27, 2026
First-Line Palbociclib/Letrozole Versus Ribociclib/Letrozole in Postmenopausal HR-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Real-World Study and an Exploratory Composite Clinical-Inflammatory Risk Score.

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 26, 2026
Enzalutamide Versus Abiraterone After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Real-World Outcomes and Exploratory Prognostic Stratification.

|Feb 07, 2026
Cardioprotective effects of dapagliflozin against doxorubicin-induced cardiotoxicity in breast cancer patients with type 2 diabetes: a prospective study.

Huseyin Ali Ozturk, Mevlut Koc, Ramazan Azim Okyay

Pageof 4

Frequent Collaborators

10 joint publications

Ali Oğul

7 joint publications

Mehmet Mutlu Kıdı

5 joint publications

Semra Paydaş

5 joint publications

Mert Tohumcuoğlu